• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

Pharma & Biotech

Bill Gates.
Posted inCOVID-19, Infections, Pharma & Biotech

Bill Gates: World Faces Danger Worse Than Coronavirus

by Alex Avisoni November 8, 2021September 8, 2022

Bioterrorism and smallpox virus — what could be worse than COVID-19.

Posted inOncology, Pharma & Biotech, Rare/Orphan Diseases

Aura Biosciences: Anticancer Virus-Like Drug Conjugates

by Julia Mardi November 1, 2021September 8, 2022

A new class of oncology drugs with a dual mechanism of action.

Posted inPharma & Biotech

Halozyme: Elegant Transformation of Drugs From Intravenous to Subcutaneous

by Timur Burkhanayev April 14, 2021September 8, 2022

Easy and quick administration of biological drugs. All for the convenience of patient care.

HIV.
Posted inInfections, Pharma & Biotech

HIV Treatment: One Pill Once a Week

by Mark Gubar April 3, 2021September 8, 2022

Lenacapavir plus islatravir is a new level of highly active antiretroviral therapy for human immunodeficiency virus infection. Gilead Sciences and Merck & Co. continue their in-depth scientific research.

Posts pagination

Newer posts 1 2
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×